New combo may ease stent pain better than standard care

NCT ID NCT07307261

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two drugs—mirabegron and tamsulosin—alone or together to relieve pain and urinary problems caused by ureteric stents. 300 adults who had a stent for the first time took part. The goal was to see which approach works best with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

mirabegron and tamsulosin (drugs)

What this could lead to

If it works, this could give doctors a better option to reduce pain and urinary symptoms from ureteric stents, with fewer side effects than current treatments.

What could go wrong

This is a completed study, but results may not apply to everyone, and individual responses to the drugs can vary. Side effects like dizziness or low blood pressure are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URETERIC STENT-RELATED MORBIDITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Qena Hospital

    Qina, Egypt